Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
1.
J Pharmacol Sci ; 127(3): 319-25, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25837929

RESUMO

Gemcitabine is widely used for pancreatic, lung, and bladder cancer. However, drug resistance against gemcitabine is a large obstacle to effective chemotherapy. Nucleoside transporters, nucleoside and nucleotide metabolic enzymes, and efflux transporters have been reported to be involved in gemcitabine resistance. Although most of the resistant factors are supposed to be related to each other, it is unclear how one factor can affect the other one. In this study, we established gemcitabine-resistant pancreatic cancer cell lines. Gemcitabine resistance in these cells is caused by two major processes: a decrease in gemcitabine uptake and overexpression of ribonucleotide reductase large subunit (RRM1). Knockdown of RRM1, but not the overexpression of concentrative nucleoside transporter 1 (CNT1), could completely overcome the gemcitabine resistance. RRM1 knockdown in gemcitabine-resistant cells could increase the intracellular accumulation of gemcitabine by increasing the nucleoside transporter expression. Furthermore, a synergistic effect was observed between hydroxyurea, a ribonucleotide reductase (RR) inhibitor, and gemcitabine on the gemcitabine-resistant cells. Here we indicate that RR is one of the most promising targets to overcome gemcitabine resistance in gemcitabine-resistant cells with dual resistant factors.


Assuntos
Antimetabólitos Antineoplásicos/farmacologia , Desoxicitidina/análogos & derivados , Resistencia a Medicamentos Antineoplásicos/genética , Inibidores Enzimáticos/farmacologia , Neoplasias Pancreáticas/patologia , Ribonucleotídeo Redutases/antagonistas & inibidores , Ribonucleotídeo Redutases/fisiologia , Desoxicitidina/metabolismo , Desoxicitidina/farmacologia , Inibidores Enzimáticos/metabolismo , Humanos , Neoplasias Pancreáticas/metabolismo , Células Tumorais Cultivadas , Gencitabina
2.
J Infect Chemother ; 18(6): 878-82, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22644082

RESUMO

UNLABELLED: Surgical site infections are a major cause of postoperative morbidity and mortality in cardiovascular surgery. Proper antibiotic prophylaxis can reduce the rate of such infections, but the concentration of antibiotic must be maintained at an adequate level throughout the operation. This study aimed to use renal function to determine the most appropriate timing for intraoperative repeated dosing of ampicillin-sulbactam, a commonly used prophylactic antibiotic, to maintain adequate concentrations throughout the course of surgery. The mean volume of distribution, elimination rate constant, elimination half-life, and total clearance of ampicillin were 13.2 l, 0.652 h⁻¹, 1.32 h, and 8.45 l/h, respectively. A statistically significant (P < 0.0001) correlation (r = 0.771) was observed between the total clearance of ampicillin and creatinine clearance of the patients. Plasma concentrations of ampicillin were simulated with the pharmacokinetic parameters obtained. We developed a nomogram for adjusting the dosing interval according to renal function and predicted ampicillin trough concentrations. We revealed the best dosage and dosing interval for cardiovascular surgery by analyzing the perioperative pharmacokinetics of ampicillin-sulbactam administered prophylactically. We suggest that the dosage and dosing interval for ampicillin-sulbactam should be adjusted to optimize treatment efficacy and safety, on the basis of the MIC90 of methicillin-sensitive Staphylococcus aureus (MSSA) in each institution. TRIAL REGISTRATION: UMIN000007356.


Assuntos
Antibacterianos/administração & dosagem , Antibacterianos/farmacocinética , Rim/efeitos dos fármacos , Idoso , Idoso de 80 Anos ou mais , Ampicilina/administração & dosagem , Ampicilina/sangue , Ampicilina/farmacocinética , Antibacterianos/sangue , Antibioticoprofilaxia/métodos , Procedimentos Cirúrgicos Cardíacos/métodos , Creatinina/urina , Feminino , Humanos , Cuidados Intraoperatórios/métodos , Rim/fisiologia , Testes de Função Renal , Masculino , Pessoa de Meia-Idade , Sulbactam/administração & dosagem , Sulbactam/sangue , Sulbactam/farmacocinética , Infecção da Ferida Cirúrgica/prevenção & controle
3.
J Infect Chemother ; 18(2): 269-71, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21894454

RESUMO

Methicillin-resistant Staphylococcus aureus (MRSA) is highly contagious. It is spread by direct contact with MRSA-infected people or objects. Healthcare workers' hands are the most common vehicle for the transmission of healthcare-associated pathogens from patient to patient and within the healthcare environment. The present study aimed to investigate the correlation between the incidence of MRSA among Staphylococcus aureus recovered from clinical culture and the use of alcohol-based hand rub solutions or gloves and antimicrobial use density (AUD). All data were examined every 6 months between January 2005 and June 2008. The increasing use of alcohol-based hand rub solutions was correlated with a decreasing incidence of recovery of MRSA from clinical cultures (r(2) = 0.58). A statistically significant (P < 0.05) correlation (r(2) = 0.68) was observed between glove use and the incidence of MRSA. On the other hand, we did not find any correlation between the AUD of each antibiotic group and the incidence of MRSA. Thus, we suggest that it is important to use not only alcohol-based hand rubs, but also gloves, because MRSA is transmitted from patient to patient by the hands of healthcare workers.


Assuntos
Álcoois/administração & dosagem , Antibacterianos/uso terapêutico , Infecção Hospitalar/epidemiologia , Luvas Protetoras/estatística & dados numéricos , Desinfecção das Mãos/métodos , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Infecções Estafilocócicas/epidemiologia , Infecção Hospitalar/microbiologia , Desinfetantes/administração & dosagem , Pessoal de Saúde , Humanos , Higiene , Incidência , Infecções Estafilocócicas/microbiologia
4.
Cancer Sci ; 102(3): 540-8, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21205070

RESUMO

Wnts are secreted ligands that consist of 19 members in humans, regulate cell proliferation, differentiation, motility and fate in many stages including the embryonic stage and tumorigenesis. Wnts bind to cell surface receptors named Frizzleds and LRPs, and transduce their signals through ß-catenin-dependent and -independent intracellular pathways. Gliomas are one of the most common intracranial tumors. Gliomas exhibit a progression associated with widespread infiltration into surrounding neuronal tissues. However, the molecular mechanisms that stimulate the invasion of glioma cells are not fully understood. We established two cell lines from human glioma cases and analyzed the expression of all Wnt and Frizzled members in these cell lines and other well-known glioma cell lines by real-time PCR study. The mRNA of Wnt-5a and -7b and Frizzled-2, -6 and -7 were overexpressed in glioma cells. The elevation of Wnt-5a expression was most remarkable. Although Wnt-5a is reported to have oncogenic and antioncogenic activity in several cancers, the role of Wnt-5a signaling in human glioma cells remains unclear. Immunohistochemical study also revealed high expression of Wnt-5a in 26 (79%) of 33 human glioma cases. The positivity of Wnt-5a expression was correlated with the clinical grade. Knockdown of Wnt-5a expression suppressed migration, invasion and expression of matrix metalloproteinase-2 of glioma cells. Reciprocally, treatment with purified Wnt-5a ligand resulted in stimulation of cell migration and invasion. MMP-2 inhibitor suppressed the Wnt-5a-dependent invasion of U251 cells. These results suggested that Wnt-5a is not only a prognostic factor but also a therapeutic target molecule in gliomas for preventing tumor cell infiltration.


Assuntos
Neoplasias Encefálicas/patologia , Movimento Celular , Glioma/patologia , Metaloproteinase 2 da Matriz/fisiologia , Proteínas Proto-Oncogênicas/fisiologia , Transdução de Sinais/fisiologia , Proteínas Wnt/fisiologia , Linhagem Celular Tumoral , Humanos , Imuno-Histoquímica , Inibidores de Metaloproteinases de Matriz , Invasividade Neoplásica , Proteínas Proto-Oncogênicas/análise , Proteínas Proto-Oncogênicas/genética , RNA Mensageiro/análise , Proteínas Wnt/análise , Proteínas Wnt/genética , Proteína Wnt-5a , beta Catenina/análise
5.
Biol Pharm Bull ; 34(9): 1418-25, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21881227

RESUMO

5-Fluorouracil (5-FU)-based chemotherapies with irinotecan have been applied for the treatment of cancers, and a common dose-limiting toxicity is neutropenia and diarrhea. In this study, we investigated the effect of 5-FU treatment on expression levels of drug transporters for SN-38 transportation and SN-38 absorption from the intestine following 5-FU treatment. Expression levels of several drug transporters and nuclear receptors in rats after 5-FU treatment were evaluated. SN-38 absorption from the intestine was evaluated by SN-38 concentration levels in serum following SN-38 injection into the intestine of 5-FU treated rats. The levels of renal multidrug resistance protein 2 (Mrp2) on day 4 after treatment (400 mg/kg) showed significant upregulation, 359.2 ± 33.2% (mean ± S.E.) of control. Mrp2 levels in the intestine were downregulated to 26.2 ± 8.4% of control. 5-FU treatment (400 mg/kg) also significantly downregurated expression levels of P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp) to 41.2 ± 14.7%, 15.7 ± 4.3% of control, respectively. To evaluate SN-38 absorption from the intestine, SN-38 was loaded in to the intestine on day 4 after 5-FU treatment. Pretreatment with 5-FU significantly increased SN-38 concentration in the blood 30, 60 and 90 min after SN-38 administration. The area under the curve for SN-38 in the 5-FU group was significantly higher than in vehicle groups. 5-FU treatment decreased expression levels of P-glycoprotein and Bcrp in intestine. The present study suggests that combination chemotherapy of 5-FU with irinotecan (CPT-11) may elevate SN-38 absorption from intestine.


Assuntos
Camptotecina/análogos & derivados , Fluoruracila/farmacologia , Absorção Intestinal/efeitos dos fármacos , Transportadores de Cassetes de Ligação de ATP/genética , Animais , Sequência de Bases , Peso Corporal/efeitos dos fármacos , Camptotecina/farmacocinética , Linhagem Celular , Primers do DNA , Humanos , Irinotecano , Masculino , Fosforilação , Reação em Cadeia da Polimerase , Proteínas Proto-Oncogênicas c-jun/metabolismo , RNA Mensageiro/genética , Ratos , Ratos Wistar , Receptores Citoplasmáticos e Nucleares/genética
6.
Biol Pharm Bull ; 34(3): 433-5, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21372398

RESUMO

Sorafenib and sunitinib is a small molecule inhibitor of certain receptor tyrosine kinases, and have improved outcomes for patients with advanced renal cell carcinoma. Inhibitory concentration of 50% cell growth of sorafenib significantly rose to 6.4-fold in a multidrug resistance protein 2 (MRP2) transfected cell line versus control cell line. The concentration of sorafenib was significantly decreased to 74% of control cells after 3 h treatment. In contrast, a tyrosine kinase inhibitor sunitinib did not show alteration of inhibitory concentration of 50% cell growth and accumulation into the cells of MRP2 transfected cells. The present study suggest that sorafenib is a substrate for MRP2, suggesting that MRP2 may implicate drug resistance to sorafenib.


Assuntos
Subfamília B de Transportador de Cassetes de Ligação de ATP/metabolismo , Antineoplásicos/metabolismo , Benzenossulfonatos/metabolismo , Resistencia a Medicamentos Antineoplásicos , Indóis/metabolismo , Inibidores de Proteínas Quinases/metabolismo , Piridinas/metabolismo , Pirróis/metabolismo , Animais , Antineoplásicos/farmacologia , Benzenossulfonatos/farmacologia , Carcinoma de Células Renais/metabolismo , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Humanos , Indóis/farmacologia , Neoplasias Renais/metabolismo , Niacinamida/análogos & derivados , Compostos de Fenilureia , Inibidores de Proteínas Quinases/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Piridinas/farmacologia , Pirróis/farmacologia , Sorafenibe , Especificidade por Substrato , Sunitinibe , Suínos , Transfecção , Membro 4 da Subfamília B de Transportadores de Cassetes de Ligação de ATP
7.
J Infect Chemother ; 17(2): 297-300, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20714913

RESUMO

Teicoplanin is a glycopeptide antibacterial agent that has a long serum half-life and therefore takes time to achieve steady-state conditions. An appropriate initial dosing is needed for teicoplanin to promptly reach an effective serum trough concentration. However, little information is available on tailoring the initial dosing for patients with various characteristics. The objective of this study was to develop a nomogram for determining teicoplanin initial dose to promptly reach an effective trough concentration (≥ 13 µg/mL). A logistic regression analysis was performed to test whether the area under the concentration time curve (AUC) is a significant predictor of microbiological response (persistence 0; eradication 1). The study included 24 adult patients with methicillin-resistant Staphylococcus aureus infections [minimal inhibitory concentration (MIC) for the isolates was <2 µg/mL). Each AUC was estimated using individual dose, creatinine clearance (CL(cr)), and body weight data. The target value, which gives about a 0.9 microbiological eradication probability, was 750 µg h/mL for AUC from zero to 24 h (AUC(0-24 h)). Using published population pharmacokinetic parameters, the dose required to achieve the AUC(0-24 h) target was calculated as dose (mg) = 750 × (0.00498 × CL(cr) (mL/min) + 0.00426 × body weight (kg). For various combinations of CL(cr) and body weight, we checked the calculated doses using a therapeutic drug monitoring (TDM)-supporting software and developed a nomogram. The nomogram would be useful for initial dose adjustment to promptly reach an effective serum trough concentration and avoid adverse events of teicoplanin.


Assuntos
Antibacterianos/administração & dosagem , Área Sob a Curva , Monitoramento de Medicamentos/métodos , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Nomogramas , Teicoplanina/administração & dosagem , Adulto , Antibacterianos/farmacocinética , Antibacterianos/uso terapêutico , Humanos , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Software , Infecções Estafilocócicas/microbiologia , Teicoplanina/farmacocinética , Teicoplanina/uso terapêutico
8.
Cancer Sci ; 101(4): 920-6, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20175781

RESUMO

Vaults are evolutionarily highly conserved ribonucleoprotein (RNP) particles with a hollow barrel-like structure. Although roles in multidrug resistance and innate immunity have been suggested, the physiological function of vaults remains unclear. Major vault protein (MVP), the main component of the vault particle, has been reported to be induced by hypoxia. However, there are no reports about the effect of vaults on cellular responses to hypoxia. We thus examined whether vaults are implicated in cellular responses to hypoxia. In this study, we focused on hypoxia-inducible factor-1alpha (HIF-1alpha), which is a master regulator of hypoxic responses, and found that: (i) MVP knockdown by RNA interference increases HIF-1alpha protein levels induced by hypoxia and hypoxia mimetics; (ii) MVP knockdown does not affect HIF-1alpha mRNA levels, but decreases the ubiquitination and degradation of HIF-1alpha protein; and (iii) vaults form complexes with HIF-1alpha, PHD2, and pVHL. Taken together, these results suggest that vaults function as scaffolds in HIF-1alpha degradation pathway and promote the ubiquitination and degradation of HIF-1alpha.


Assuntos
Adenocarcinoma/metabolismo , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Neoplasias Renais/metabolismo , Partículas de Ribonucleoproteínas em Forma de Abóbada/metabolismo , Hipóxia Celular , Linhagem Celular Tumoral , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/genética , Interferência de RNA , RNA Mensageiro/metabolismo , Ubiquitinação , Partículas de Ribonucleoproteínas em Forma de Abóbada/genética
9.
J Infect Chemother ; 16(3): 193-9, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20195882

RESUMO

An initial loading procedure has been recommended to enable teicoplanin to promptly reach an effective serum concentration for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). This study aimed to retrospectively evaluate the pharmacokinetics and pharmacodynamics of teicoplanin to determine the therapeutic target for the teicoplanin trough concentration and an appropriate dosing method during the first 3 days. The mean trough concentrations were 13.2 mg/L for patients with eradication of MRSA. Moreover, logistic regression analysis showed that the teicoplanin trough concentration was 13 mg/L to achieve MRSA eradication with a probability of 89.0%. The rates of achieving >or=13 mg/L in or=36 mg/kg (total dose during the first 3 days) groups were 9.1, 48.4 and 87.5%, respectively. These results suggest that the administration of >or=36 mg/kg during the first 3 days is appropriate to promptly obtain a trough concentration target of >or=13 mg/L for the initial treatment of MRSA infections.


Assuntos
Antibacterianos/administração & dosagem , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Infecções Estafilocócicas/tratamento farmacológico , Teicoplanina/administração & dosagem , Teicoplanina/sangue , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/sangue , Antibacterianos/farmacocinética , Monitoramento de Medicamentos/métodos , Feminino , Humanos , Testes de Função Renal , Testes de Função Hepática , Modelos Logísticos , Masculino , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Pessoa de Meia-Idade , Estudos Retrospectivos , Infecções Estafilocócicas/sangue , Teicoplanina/farmacocinética
10.
J Neurochem ; 109(1): 158-67, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19166515

RESUMO

To identify proteins interacting with the intracellular domain of the neural cell adhesion molecule contactin-associated protein 2 (Caspr2), yeast two-hybrid screening was performed. We identified carboxypeptidase E (CPE) as a Caspr2-interacting candidate protein. Glutathione S-transferase pull-down and immunoprecipitation analyses indicated that Caspr2 was associated with CPE in vitro and in vivo. Both Caspr2 and CPE were expressed predominantly in the CNS. Immunohistochemical analyses revealed that both Caspr2- and CPE-like immunoreactivities were found to co-localize in the apical dendrites and cell bodies of rat cortical neurons. In subcellular localization analysis, Caspr2- and CPE-like immunoreactivities were co-migrated in the fractions of Golgi/ER. Additionally, in COS-7 cells co-transfected with CPE and Caspr2 cDNAs, Caspr2- and CPE-immunoreactivities were co-localized in both Golgi and membrane, whereas it was only observed in Golgi of either COS-7 cell transfected with CPE or Caspr2 cDNA alone. It is known that the membrane-bound form of CPE functions as a sorting receptor of prohormones in the trans-Golgi network. Taken together, our data suggest that CPE may be a key molecule to regulate Caspr2 trafficking to the cell membrane.


Assuntos
Carboxipeptidase H/metabolismo , Sistema Nervoso Central/metabolismo , Proteínas de Membrana/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Animais , Células COS , Carboxipeptidase H/fisiologia , Sistema Nervoso Central/enzimologia , Córtex Cerebral/enzimologia , Córtex Cerebral/metabolismo , Chlorocebus aethiops , Humanos , Masculino , Proteínas de Membrana/fisiologia , Proteínas do Tecido Nervoso/fisiologia , Ligação Proteica/fisiologia , Transporte Proteico/fisiologia , Ratos , Ratos Wistar
11.
Exp Cell Res ; 314(16): 3017-26, 2008 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-18671966

RESUMO

The major vault protein (MVP) is the major constituent of the vault particle, the largest ribonuclear protein complex described to date and is identical to lung resistance-related protein (LRP). Although MVP is also expressed in several normal tissues, little is known about its physiological role. MVP played a protective role against some xenobiotics and other stresses. We thus investigated the effect of osmotic stress on MVP expression by treating human colon cancer SW620 cells with sucrose or NaCl. The expression level of both MVP protein and MVP mRNA was increased by the osmostress. Sucrose or sodium chloride could also enhance MVP promoter activity. Inhibition of p38 MAPK in SW620 cells by SB203580 inhibited the expression of MVP under hyperosmotic stress. These findings suggested that osmotic stress up-regulated the MVP expression through p38 MAPK pathway. Down-regulation of MVP expression by MVP interfering RNA (RNAi) in SW620 cells increased the sensitivity of the cells to hyperosmotic stress and enhanced apoptosis. Furthermore, MVP RNAi prevented the osmotic stress-induced, time-dependent increase in phosphorylated Akt. These findings suggest that the PI3K/Akt pathway might be implicated in the cytoprotective effect of MVP. Our data demonstrate that exposure of cells to hyperosmotic stress induces MVP that might play an important role in the protection of the cells from the adverse effects of osmotic stress.


Assuntos
Linhagem Celular Tumoral , Neoplasias do Colo/metabolismo , Regulação da Expressão Gênica , Partículas de Ribonucleoproteínas em Forma de Abóbada/metabolismo , Animais , Sobrevivência Celular , Cromonas/metabolismo , Inibidores Enzimáticos/metabolismo , Genes Reporter , Humanos , Morfolinas/metabolismo , Pressão Osmótica , Regiões Promotoras Genéticas , Interferência de RNA , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Cloreto de Sódio/metabolismo , Sacarose/metabolismo , Partículas de Ribonucleoproteínas em Forma de Abóbada/genética , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
12.
Cancer Sci ; 99(8): 1618-25, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18754875

RESUMO

Paclitaxel-induced painful peripheral neuropathy is a major dose-limiting factor. Recently, it has been reported that macrophages accumulated in the dorsal root ganglion of paclitaxel-treated rats, and their activation is suggested to contribute to generation and development of the neuropathy. However, the mechanism for macrophage activation is still unknown. In this study, to explore candidate genes involved in the mechanism for macrophage activation in the dorsal root ganglion of paclitaxel-treated rats, we developed model rats for paclitaxel-induced neuropathic pain and performed a microarray assay to analyze the changes of gene expressions in the dorsal root ganglion. Among the genes with changed expression levels, we focused on matrix metalloproteinase-3 (MMP-3, stromelysin-1) and CD163, a macrophage marker. By reverse transcription-polymerase chain reaction, the expression levels of MMP-3 and CD163 were markedly up-regulated in paclitaxel-treated dorsal root ganglion. As a result of immunohistochemical study, large ganglion neurons, but neither Schwann cells nor macrophages, predominantly expressed MMP-3. This MMP-3 up-regulation occurred prior to macrophage accumulation in the dorsal root ganglion. In addition, recombinant MMP-3 led to the activation of RAW264 macrophages in vitro. Taken together, the up-regulation of MMP-3 and following macrophage activation caused in the dorsal root ganglion might be a significant event to trigger a series of reactions developing paclitaxel-induced peripheral neuropathic pain.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Gânglios Espinais/metabolismo , Metaloproteinase 3 da Matriz/biossíntese , Paclitaxel/farmacologia , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Regulação para Cima , Animais , Antígenos CD/biossíntese , Antígenos de Diferenciação Mielomonocítica/biossíntese , Expressão Gênica , Ratos , Receptores de Superfície Celular/biossíntese
13.
Biochem Biophys Res Commun ; 370(2): 220-4, 2008 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-18359286

RESUMO

An angiogenic factor, thymidine phosphorylase (TP), confers resistance to apoptosis induced by hypoxia. We investigated the molecular basis for the suppressive effect of TP on hypoxia-induced apoptosis using Jurkat cells transfected with TP cDNA, Jurkat/TP, and a mock transfectant, Jurkat/CV. TP and 2-deoxy-d-ribose, a degradation product of thymidine generated by TP enzymatic activity, suppressed hypoxia-induced apoptosis. They also inhibited the upregulation of hypoxia-inducible factor (HIF) 1alpha and the proapoptotic factor, BNIP3, and caspase 3 activation induced by hypoxia. Introduction of siRNA against BNIP3 in Jurkat cells decreased the proportion of apoptotic cells under hypoxic condition. These findings suggest that the suppression of BNIP3 expression by TP prevents, at least in part, hypoxia-induced apoptosis. Expression levels of TP are elevated in many malignant solid tumors and thus 2-deoxy-d-ribose generated by TP in these tumors might play an important role in tumor progression by preventing hypoxia-induced apoptosis.


Assuntos
Apoptose , Proteínas de Membrana/antagonistas & inibidores , Proteínas Proto-Oncogênicas/antagonistas & inibidores , Timidina Fosforilase/metabolismo , Apoptose/efeitos dos fármacos , Apoptose/genética , Caspase 3/metabolismo , Caspase 8/metabolismo , Hipóxia Celular/genética , Desoxirribose/metabolismo , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Células Jurkat , Proteínas de Membrana/genética , Proteínas Proto-Oncogênicas/genética , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/farmacologia , Timidina Fosforilase/genética , Transfecção
14.
Environ Toxicol Chem ; 27(6): 1354-60, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18198945

RESUMO

In a previous study, we showed that Hg accumulated to high levels in the liver of the Javan mongoose (Herpestes javanicus), a terrestrial mammal that lives on Amamioshima Island, Japan. This suggests a sophisticated mechanism of hepatic Hg detoxication. Assay of the subcellular localization of Hg and the expression of protective enzymes provides important clues for elucidating the mechanism of Hg detoxication. In the present study, the concentrations of 11 elements (Mg, Cr, Mn, Fe, Cu, Zn, Se, Rb, Cd, total Hg [T-Hg] and organic Hg [O-Hg], and Pb) were determined in the liver and in five liver subcellular fractions (plasma membrane, mitochondria, nuclei, microsome, and cytosol) of this species. As the T-Hg level increased, T-Hg markedly distributed to the plasma membrane. The T-Hg levels in all subcellular fractions correlated with Se levels. Although the T-Hg level in the microsomal fraction was relatively low, the ratio of O-Hg to T-Hg was significantly lower in the microsomes than in the other fractions. Significant positive correlations were found between the level of glutathione-S-transferase-pi, a marker of oxidative stress, and the O-Hg and T-Hg levels, but the correlation was better with O-Hg than with T-Hg. Western blot analysis of thioredoxin reductase 2 (TrxR2), a protein involved in protecting cells from mitochondrial oxidative stress, showed that the level of TrxR2 correlated with that of T-Hg. High TrxR2 levels may be one mechanism by which the Javan mongoose attenuates the toxicity of the high Hg levels present in the liver.


Assuntos
Herpestidae/metabolismo , Fígado/citologia , Fígado/efeitos dos fármacos , Mercúrio/metabolismo , Mercúrio/toxicidade , Animais , Geografia , Inativação Metabólica , Japão , Fígado/metabolismo
15.
Life Sci ; 81(2): 103-8, 2007 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-17543347

RESUMO

An herbal health care supplement, St John's Wort (SJW, Hypericum perforatum) has become widely used in the treatment of depression, and is known to interact with therapeutic drugs. Here we report a preventive effect of SJW on cisplatin nephrotoxicity in rats. Rats were given SJW (400 mg/kg/day, p.o.) for 10 consecutive days, and were injected with cisplatin (5 mg/kg, i.v.) on the day after the final SJW treatment. Cisplatin treatment increased the serum creatinine level, which is an index of nephrotoxicity, to 1.51+/-0.22 mg/dl (mean+/-SE) from 0.28+/-0.05 mg/dl (control) on day 5 after the cisplatin injection. This increase fell significantly to 0.86+/-0.13 mg/dl by pre-treatment with SJW. Cisplatin-induced histological abnormality of the kidney was blocked by pre-treatment with SJW. When SJW was administered for 10 days, the amounts of renal metallothionein (MT) and hepatic multidrug resistance protein 2 (Mrp2) were increased to 164.8+/-13.0% and 220.8+/-39.3% (mean+/-SE) of controls, respectively. GSH levels in the kidney and liver were not changed. Total and free cisplatin concentration in serum was not influenced by SJW treatment. In conclusion, the results suggest that pre-treatment with SJW may diminish cisplatin nephrotoxicity.


Assuntos
Antineoplásicos/antagonistas & inibidores , Antineoplásicos/toxicidade , Cisplatino/antagonistas & inibidores , Cisplatino/toxicidade , Hypericum , Nefropatias/induzido quimicamente , Transportadores de Cassetes de Ligação de ATP/metabolismo , Animais , Antineoplásicos/farmacocinética , Peso Corporal/efeitos dos fármacos , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Cisplatino/farmacocinética , Creatinina/sangue , Interações Medicamentosas , Glutationa/metabolismo , Rim/efeitos dos fármacos , Rim/metabolismo , Nefropatias/metabolismo , Masculino , Metalotioneína/metabolismo , Ratos , Ratos Wistar
16.
Am J Chin Med ; 45(7): 1497-1511, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29025293

RESUMO

Berberine (BBR), an isoquinoline alkaloid, is a well-known bioactive compound contained in medicinal plants used in traditional and folk medicines. In this study, we investigated the subcellular localization and the apoptotic mechanisms of BBR were elucidated. First, we confirmed the incorporation of BBR into the cell visually. BBR showed antiproliferative activity and promptly localized to the nucleus from 5[Formula: see text]min to 15[Formula: see text]min after BBR treatment in HL-60 human promyelocytic leukemia cells. Next, we examined the antiproliferative activity of BBR (1) and its biosynthetically related compounds (2-7) in HL-60 cells. BBR exerted strongest antiproliferative activity among 1-7 and the results of structures and activity relation suggested that a methylenedioxyl group in ring A, an [Formula: see text]-alkyl group at C-9 position, and the frame of isoquinoline may be necessary for antiproliferative activity. Moreover, BBR showed the most potent antiproliferative activity in HL-60 cells among human cancer and normal cell lines tested. Next, we examined the effect of BBR on molecular events known as apoptosis induction. In HL-60 cells, BBR induced chromatin condensation and DNA fragmentation, and triggered the activation of PARP, caspase-3 and caspase-8 without the activation of caspase-9. BBR-induced DNA fragmentation was abolished by pretreatment with inhibitors against caspase-3 and caspase-8, but not against caspase-9. ERK and p38 were promptly phosphorylated after 15 min of BBR treatment, and this was correlated with time of localization to the nucleus of BBR. These results demonstrated that BBR translocated into nucleus immediately after treatments and induced apoptotic cell death by activation of caspase-3 and caspase-8.


Assuntos
Apoptose/efeitos dos fármacos , Berberina/metabolismo , Berberina/farmacologia , Caspase 3/metabolismo , Caspase 8/metabolismo , Núcleo Celular/metabolismo , Leucemia Promielocítica Aguda/patologia , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Cromatina/metabolismo , Fragmentação do DNA/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Células HL-60 , Humanos , Leucemia Promielocítica Aguda/metabolismo , Fosforilação/efeitos dos fármacos , Relação Estrutura-Atividade , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
17.
Ann N Y Acad Sci ; 1070: 586-90, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16888230

RESUMO

Pituitary adenylate cyclase-activating polypeptide (PACAP), a pleiotropic neuropeptide, exerts a variety of physiological functions through three types of G protein-coupled receptors, PAC1, VPAC1, and VAPC2. Characterization of the molecular forms of PAC1 in mouse heart revealed the presence of four types of variant receptors harboring the N or S variant in the first extracellular domain (EC1 domain) with or without the HOP1 insert in the third intracellular cytoplasmic loop (IC3 loop). Then, we assessed the binding affinity and ability to stimulate adenylyl cyclase of the PCA1 variant-expressing cells for PACAP. Adenylyl cyclase activation by PACAP was markedly influenced with the variant in the EC1 domain as well as that in the IC3 loop, in spite of a little difference in their binding properties. These data suggest that the combination of EC1 domain variants and IC3 loop variants might account for the diversity of intracellular signaling, which might contribute to multiple functions of PACAP including a role in the cardiovascular system.


Assuntos
Variação Genética/genética , Miocárdio/metabolismo , Receptores de Polipeptídeo Hipofisário Ativador de Adenilato Ciclase/genética , Receptores de Polipeptídeo Hipofisário Ativador de Adenilato Ciclase/metabolismo , Animais , Células CHO , Cricetinae , AMP Cíclico/metabolismo , Camundongos
18.
Chemosphere ; 65(4): 657-65, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16563464

RESUMO

Concentrations of 22 elements (Mg, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Rb, Sr, Mo, Ag, Cd, Sb, Cs, Ba, Tl, total Hg (T-Hg), Pb) and organic Hg (O-Hg) were examined in the liver, kidney and brain of the Javan mongoose (Herpestes javanicus) and in liver of the Amami rabbit (Pentalagus furnessi) from Amamioshima Island in Japan. Relatively high levels of T-Hg levels (from 1.75 to 55.5 microg g-1 wet wt.) were found in the Javan mongoose. As for a comparison of hepatic T-Hg concentrations between the two areas, there was no significant difference between the Javan mongoose in Amamioshima and those in the Okinawa islands. In addition, T-Hg levels in the livers of the Amami rabbit were the same as in the livers of other herbivorous mammals. Taken together, it suggested that T-Hg accumulation in the livers of the Javan mongoose was not affected by the environment but by a specific physiological mechanism. The comparison of Hg and other heavy metal accumulations between terrestrial mammals (13 species, 61 individuals) including the Javan mongoose and marine mammals (18 species, 508 individuals) were also discussed.


Assuntos
Monitoramento Ambiental , Poluentes Ambientais/análise , Herpestidae/crescimento & desenvolvimento , Metais Pesados/análise , Animais , Poluentes Ambientais/farmacocinética , Herpestidae/metabolismo , Japão , Mercúrio/análise , Mercúrio/farmacocinética , Metais Pesados/farmacocinética
19.
Environ Sci ; 13(3): 149-60, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16883297

RESUMO

In order to evaluate the current arsenic exposure status and its determinants in Japan, we collected toenail samples from 212 subjects residing in a town with a population of 6,900 in Amami-Oshima Island in August 1999. We measured arsenic concentrations of the toenails using inductively coupled plasma mass spectrometry. In addition, we examined the association of arsenic levels with lifestyles and dietary habits, including the consumption of fish, seaweed, and rice. The mean toenail arsenic level was 0.41 ppm (95% confidence interval, 0.36-0.47), which was about 3-fold higher than those observed in other populations of mainland Kagoshima. Arsenic levels were elevated among current smokers (mean = 0.65; 95% confidence interval, 0.32-1.29) when compared with non-smokers (mean = 0.40; 95% confidence interval, 0.34-0.46), and among the residents consuming 4 bowls or more, of rice every day (mean = 1.97; 95% confidence interval, 0.25-15.75) when compared to residents consuming 3 bowls or less (mean = 0.39; 95% confidence interval, 0.34-0.45). Sex, age, alcohol intake, fish consumption, or seaweed consumption was not associated with toenail arsenic concentration. Further studies seem warranted to examine the cause of relatively high arsenic levels in our study area.


Assuntos
Arsênio/farmacocinética , Unhas/metabolismo , Idoso , Idoso de 80 Anos ou mais , Animais , Arsênio/análise , Dieta , Exposição Ambiental , Feminino , Peixes , Humanos , Japão , Estilo de Vida , Masculino , Unhas/química , Oryza , Alga Marinha , Fumar/efeitos adversos
20.
Nutrition ; 21(6): 639-49, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15925286

RESUMO

OBJECTIVE: Polyunsaturated fatty acid supplementation may produce beneficial effects after surgery. We investigated the influence of preoperative administration of a supplement rich in arginine, omega-3 fatty acids, and RNA, Impact (Japan), on inflammatory and immune responses in patients undergoing major surgery for cancer. METHODS: Patients in the supplement group (n = 12) received 1 L/d of Impact (Japan) for 5 d before surgery, and those in the control group (n = 14) received an ordinary diet without Impact (Japan) before surgery. Plasma levels of omega-3 and omega-6 fatty acids, thromboxane B(2), prostaglandin E(2), inflammatory markers, nutritional markers, cytokines, and cytokine receptors were obtained 5 d before the operation at the starting point of supplementation in the supplement group. Samples were collected on postoperative days (PODs) 0, 1, 3, and 7. RESULTS: After taking the supplement, significant increases in omega-3 fatty acids and rapid turnover proteins were found the day after ending supplementation (POD-0), whereas thromboxane B(2) levels and the ratio of omega-6 fatty acids to omega-3 fatty acids were significantly lower than before supplementation (P < 0.001). On POD-0 only, inflammatory markers and cytokine receptors in the supplement group showed low levels in comparison with the control group (P < 0.05). On POD-1 and POD-3, remarkable decreases in polymorphonuclear leukocyte-elastase and interleukin-8 in the supplement group were observed. CONCLUSION: Our findings suggest that oral administration of a supplement rich in omega-3 fatty acids for 5 d before surgery may improve not only preoperative nutritional status but also preoperative and postoperative inflammatory and immune responses in patients who have cancer.


Assuntos
Neoplasias do Sistema Digestório/cirurgia , Ácidos Graxos Ômega-3/administração & dosagem , Estado Nutricional , Cuidados Pré-Operatórios/métodos , Adulto , Idoso , Arginina/administração & dosagem , Citocinas/biossíntese , Citocinas/imunologia , Suplementos Nutricionais , Neoplasias do Sistema Digestório/tratamento farmacológico , Neoplasias do Sistema Digestório/imunologia , Dinoprostona/metabolismo , Ácidos Graxos Ômega-3/sangue , Ácidos Graxos Ômega-6/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cuidados Pós-Operatórios/métodos , Complicações Pós-Operatórias/prevenção & controle , Período Pós-Operatório , Receptores de Citocinas/metabolismo , Tromboxano B2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA